Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA: Malignant glioma: genetics and biology of a grave matter. Genes Dev. 2001, 15: 1311-1333. 10.1101/gad.891601
Article
CAS
PubMed
Google Scholar
Aster JC, Blacklow SC: Targeting the Notch pathway: twists and turns on the road to rational therapeutics. J Clin Oncol. 2012, 30 (19): 2418-2420. 10.1200/JCO.2012.42.0992
Article
CAS
PubMed
Google Scholar
Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B, Miele L: Targeting Notch to target cancer stem cells. Clin Cancer Res. 2010, 16 (12): 3141-3152. Review, 10.1158/1078-0432.CCR-09-2823
Article
PubMed Central
CAS
PubMed
Google Scholar
Takebe N, Nguyen D, Yang SX: Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther. 2014, 141 (2): 140-149. 10.1016/j.pharmthera.2013.09.005
Article
PubMed Central
CAS
PubMed
Google Scholar
Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I, Maric D, Eberhart CG, Fine HA: Expression of Notch-1 and its ligands, delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res. 2005, 65 (6): 2353-2363. 10.1158/0008-5472.CAN-04-1890
Article
CAS
PubMed
Google Scholar
Dufraine J, Funahashi Y, Kitajewski J: Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene. 2008, 27 (38): 5132-5137. 10.1038/onc.2008.227
Article
PubMed Central
CAS
PubMed
Google Scholar
Fortini ME: Gamma-secretase-mediated proteolysis in cell-surface-receptor signaling. Nat Rev Mol Cell Biol. 2002, 2 (9): 673-684.
Article
Google Scholar
Ronchini C, Capobianco AJ: Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). Mol Cell Biol. 2001, 21 (17): 5925-5934. 10.1128/MCB.21.17.5925-5934.2001
Article
PubMed Central
CAS
PubMed
Google Scholar
Sicinska E, Aifantis I, Le Cam L, Swat W, Borowski C, Yu Q, Ferrando AA, Levin SD, Geng Y, Von Boehmer H, Sicinki P: Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell. 2003, 4 (6): 451-461. 10.1016/S1535-6108(03)00301-5
Article
CAS
PubMed
Google Scholar
Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C, Del Bianco C, Rodriguez CG, Sai H, Tobias J, Li Y, Wolfe MS, Shachaf C, Felsher D, Blacklow SC, Pear WS, Aster JC: c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 2006, 20: 2096-2109. 10.1101/gad.1450406
Article
PubMed Central
CAS
PubMed
Google Scholar
Chen Y, Fischer WH, Gill GN: Regulation of the ERBB-2 promoter by RBPJkappa and NOTCH. J Biol Chem. 1997, 272 (22): 14110-14114. 10.1074/jbc.272.22.14110
Article
CAS
PubMed
Google Scholar
Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A, Holland E: Glioblastoma subclasses can be defined by activity among signal transduction pathway and associated genomic alterations. PLoS One. 2009, 4 (11): e7752- 10.1371/journal.pone.0007752
Article
PubMed Central
PubMed
Google Scholar
Le Mercier M, Hastir D, Moles Lopez X, De Neve N, Maris C, Trepant AL, Rorive S, Decaestecker C, Salmon I: A simplified approach for the molecular classification of Glioblastomas. PLoS One. 2012, 7 (9): e45475- 10.1371/journal.pone.0045475
Article
PubMed Central
CAS
PubMed
Google Scholar
Halatsch ME, Schmidt U, Behnke-Mursch J, Unterberg A, Wirtz CR: Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours. Cancer Treat. 2006, 32: 74-89. 10.1016/j.ctrv.2006.01.003.
Article
CAS
Google Scholar
Gan HK, Kaye AH, Luwor RB: The EGFRvIII variant in glioblastoma multiforme. J Clin Neurosci. 2009, 16: 748-754. 10.1016/j.jocn.2008.12.005
Article
CAS
PubMed
Google Scholar
, : The Cancer Genome Atlas project. Comprehensive genomic characterization defines human glioblastoma genes and core pathway. Nature. 2008, 455: 1061-1068. 10.1038/nature07385
Article
Google Scholar
Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, Huang HJ: A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci U S A. 1994, 91: 7727-7731. 10.1073/pnas.91.16.7727
Article
PubMed Central
CAS
PubMed
Google Scholar
Dai C, Celestino JC, Okada Y, Luois DN, Fuller GN, Holland EC: PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 2001, 15: 1913-1925. 10.1101/gad.903001
Article
PubMed Central
CAS
PubMed
Google Scholar
Assanah M, Lochhead R, Ogden A, Bruce J, Goldman J, Canoll P: Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci. 2006, 26: 6781-6790. 10.1523/JNEUROSCI.0514-06.2006
Article
CAS
PubMed
Google Scholar
Fredriksson L, Li H, Eriksson U: The PDGF family: four gene products forms five dimeric isoforms. Cytokine Growth Factor Rev. 2004, 15: 197-204. 10.1016/j.cytogfr.2004.03.007
Article
CAS
PubMed
Google Scholar
Blume-Jensen P, Hunter T: Oncogenic kinase signalling. Nature. 2001, 411 (6835): 355-365. 10.1038/35077225
Article
CAS
PubMed
Google Scholar
Kim Y, Kim E, Wu Q, Guryanova O, Hitomi M, Lathia JD, Serwanski D, Sloan AE, Weil RJ, Lee J, Nishiyama A, Bao S, Hjelmeland AB, Rich JN: Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity. Genes Dev. 2012, 26 (11): 1247-1262. 10.1101/gad.193565.112
Article
PubMed Central
CAS
PubMed
Google Scholar
Akhavan D, Pourzia AL, Nourian AA, Williams KJ, Nathanson D, Babic I, Villa GR, Tanaka K, Nael A, Yang H, Dang J, Vinters HV, Yong WH, Flagg M, Tamanoi F, Sasayama T, James CD, Kornblum HI, Cloughesy TF, Cavenee WK, Bensinger SJ, Mischel PS: De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients. Cancer Discov. 2013, 3 (5): 534-547. 10.1158/2159-8290.CD-12-0502
Article
PubMed Central
CAS
PubMed
Google Scholar
Piccirillo SG, Combi R, Cajola L, Patrizi A, Redaelli S, Bentivegna A, Baronchelli S, Maira G, Pollo B, Mangiola A, DiMeco F, Dalprà L, Vescovi AL: Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution. Oncogene. 2009, 28 (15): 1807-1811. 10.1038/onc.2009.27
Article
CAS
PubMed
Google Scholar
Mangiola A, Saulnier N, De Bonis P, Orteschi D, Sica G, Lama G, Pettorini BL, Sabatino G, Zollino M, Lauriola L, Colabianchi A, Proietti G, Kovacs G, Maira G, Anile C: Gene expression profile of Glioblastoma peritumoral tissue: an ex vivo study. PLoS One. 2013, 8 (3): e57145- 10.1371/journal.pone.0057145
Article
PubMed Central
CAS
PubMed
Google Scholar
Fortini ME: Notch signaling: the core pathway and its posttranslational regulation. Dev Cell. 2009, 19: 633-647.
Article
Google Scholar
Wall DS, Mears AJ, McNeill B, Mazerolle C, Thurig S, Wang Y, Kageyama R, Wallace VA: Progenitor cell proliferation in the retina is dependent on Notch-independent Sonic hedgehog/Hes1 activity. J Cell Biol. 2009, 184 (1): 101-112. 10.1083/jcb.200805155
Article
PubMed Central
CAS
PubMed
Google Scholar
Chen J, Huang Q, Wang F: Inhibition of FoxO1 nuclear exclusion prevents metastasis of Glioblastoma. Tumour Biol. 2014, Apr 27. (Epub ahead of print),
Google Scholar
Zhang X, Chen T, Zhang J, Mao Q, Li S, Xiong W, Qiu Y, Xie Q, Ge J: Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation. Cancer Sci. 2012, 103 (2): 181-190. 10.1111/j.1349-7006.2011.02154.x
Article
CAS
PubMed
Google Scholar
Vivanco I, Mellinghoff IK: Epidermal growth factor receptor inhibitors in oncology. Curr Opin Oncol. 2010, 22 (6): 573-578. 10.1097/CCO.0b013e32833edbdf
Article
CAS
PubMed
Google Scholar
Peereboom DM, Shepard DR, Ahluwalia MS, Brewer CJ, Agarwal N, Stevens GH, Suh JH, Toms SA, Vogelbaum MA, Weil RJ, Elson P, Barnett GH: Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme. J Neurooncol. 2010, 98 (1): 93-99. 10.1007/s11060-009-0067-2
Article
CAS
PubMed
Google Scholar
Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS: Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer. 2006, 5: 67- 10.1186/1476-4598-5-67
Article
PubMed Central
PubMed
Google Scholar
Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG: NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells. 2010, 28 (1): 5-16.
PubMed Central
CAS
PubMed
Google Scholar
Krop I, Demuth T, Guthrie T, Wen PY, Mason WP, Chinnaiyan P, Butowski N, Groves MD, Kesari S, Freedman SJ, Blackman S, Watters J, Loboda A, Podtelezhnikov A, Lunceford J, Chen C, Giannotti M, Hing J, Beckman R: Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. J Clin Oncol. 2012, 30 (19): 2307-2313. 10.1200/JCO.2011.39.1540
Article
CAS
PubMed
Google Scholar
Alentorn A, Marie Y, Carpentier C, Boisselier B, Giry M, Labussiere M, Mokhtari K, Hoang-Xuan K, Sanson M, Delattre JY, Idbaih A: Prevalence, clinico-pathological value, and cooccurrence of PDGFRA abnormalities in diffuse gliomas. Neuro Oncol. 2012, 14 (11): 1393-1403. 10.1093/neuonc/nos217
Article
PubMed Central
CAS
PubMed
Google Scholar
Kamakura S, Oishi K, Yoshimatsu T, Nakafuku M, Masuyama N, Gotoh Y: Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol. 2004, 6 (6): 547-554. 10.1038/ncb1138
Article
CAS
PubMed
Google Scholar
Garner JM, Fan M, Yang CH, Du Z, Sims M, Davidoff AM, Pfeffer LM: Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway. J Biol Chem. 2013, 288 (36): 26167-26176. 10.1074/jbc.M113.477950
Article
PubMed Central
CAS
PubMed
Google Scholar
Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, DingL GT, Mesirov JP, Alexe G, Lawrence M, O’Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G: Cancer Genome Atlas Research Network: integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010, 17 (1): 98-110. 10.1016/j.ccr.2009.12.020
Article
PubMed Central
CAS
PubMed
Google Scholar
Purow BW, Sundaresan TK, Burdick MJ, Kefas BA, Comeau LD, Hawkinson MP, Su Q, Kotliarov Y, Lee J, Zhang W, Fine HA: Notch-1 regulates transcription of the epidermal growth factor receptor through p53. Carcinogenesis. 2008, 29 (5): 918-925. 10.1093/carcin/bgn079
Article
PubMed Central
CAS
PubMed
Google Scholar
Xu P, Qiu M, Zhang Z, Kang C, Jiang R, Jia Z, Wang G, Jiang H, Pu P: The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo. J Neurooncol. 2010, 97 (1): 41-51. 10.1007/s11060-009-0007-1
Article
CAS
PubMed
Google Scholar
Ghosh MK, Sharma P, Harbor PC, Rahaman SO, Haque SJ: PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells. Oncogene. 2005, 24 (49): 7290-7300. 10.1038/sj.onc.1208894
Article
CAS
PubMed
Google Scholar
Liu Q, Li G, Li R, Shen J, He Q, Deng L, Zhang C, Zhang J: IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines. J Neurooncol. 2010, 100 (2): 165-176. 10.1007/s11060-010-0158-0
Article
CAS
PubMed
Google Scholar
Uhrbom L, Hesselager G, Nister M, Westermark B: Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 1998, 58: 5275-5279.
CAS
PubMed
Google Scholar
Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN: Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest. 1990, 86: 131-140. 10.1172/JCI114675
Article
PubMed Central
CAS
PubMed
Google Scholar
Plate KH, Breier G, Farrell CL, Risau W: Platelet-derived growth factor receptor-b is induced during tumor development and upregulated during tumor progression in endothe- lial cells in human gliomas. Lab Invest. 1992, 67: 529-534.
CAS
PubMed
Google Scholar
Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, Depinho RA, Cavenee WK: Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007, 21: 2683-2710. 10.1101/gad.1596707
Article
CAS
PubMed
Google Scholar
Feng H, Liu KW, Guo P, Zhang P, Cheng T, McNiven MA, Johnson GR, Hu B, Cheng SY: Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion. Oncogene. 2012, 31 (21): 2691-2702. 10.1038/onc.2011.436
Article
PubMed Central
CAS
PubMed
Google Scholar
Szerlip NJ, Pedraza A, Chakravarty D, Azim M, McGuire J, Fang Y, Ozawa T, Holland EC, Huse JT, Jhanwar S, Leversha MA, Mikkelsen T, Brennan CW: Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Proc Natl Acad Sci U S A. 2012, 109 (8): 3041-3046. 10.1073/pnas.1114033109
Article
PubMed Central
CAS
PubMed
Google Scholar
Stommel JM, Kimmelman AC, Ying H, Nabioullin R, Ponugoti AH, Wiedemeyer R, Stegh AH, Bradner JE, Ligon KL, Brennan C, Chin L, DePinho RA: Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science. 2007, 318 (5848): 287-290. 10.1126/science.1142946
Article
CAS
PubMed
Google Scholar
Lama G, Angelucci C, Recchia F, Sica G: Combined effects of 13-cis-retinoic acid, tamoxifen and interferon on the growth of human breast cancer cells. Cancer Lett. 1996, 100 (1–2): 181-189. Erratum in: Cancer Lett 1996, 103 (2): 243,
Article
CAS
PubMed
Google Scholar